CLINICAL_TRIALS
trial_result
· 2014-01-28
Clinical Trial Update: PDE Inhibitors in DMD Study (Acute Dosing Study) [Phase 1]
Summary
Phase 1 acute dosing study of PDE inhibitors in Duchenne Muscular Dystrophy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Cedars-Sinai Medical Center | Conditions: Duchenne Muscular Dystrophy | Phase 1 | Status: COMPLETED